AAAAAA

   
Results: 1-9 |
Results: 9
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives
Authors: Runnebaum, IB Wang-Gohrke, S Vesprini, D Kreienberg, R Lynch, H Moslehi, R Ghadirian, P Weber, B Godwin, AK Risch, H Garber, J Lerman, C Olopade, OI Foulkes, WD Karlan, B Warner, E Rosen, B Rebbeck, T Tonin, P Dube, MP Kieback, DG Narod, SA
Citation: Ib. Runnebaum et al., Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives, PHARMACOGEN, 11(7), 2001, pp. 635-638
Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study
Authors: Narod, SA Sun, P Ghadirian, P Lynch, H Isaacs, C Garber, J Weber, B Karlan, B Fishman, D Rosen, B Tung, N Neuhausen, SL
Citation: Sa. Narod et al., Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study, LANCET, 357(9267), 2001, pp. 1467-1470
Founder mutations of BRCA1 and BRCA2 in North American families of Polish origin that are affected with breast cancer
Authors: de los Rios, P Jack, E Kuperstein, G Lynch, H Lubinski, J Narod, SA
Citation: P. De Los Rios et al., Founder mutations of BRCA1 and BRCA2 in North American families of Polish origin that are affected with breast cancer, AM J HU GEN, 68(2), 2001, pp. 546-546
Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer
Authors: Grady, WM Willis, J Guilford, PJ Dunbier, AK Toro, TT Lynch, H Wiesner, G Ferguson, K Eng, C Park, JG Kim, SJ Markowitz, S
Citation: Wm. Grady et al., Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer, NAT GENET, 26(1), 2000, pp. 16-17
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study
Authors: Narod, SA Brunet, JS Ghadirian, P Robson, M Heimdal, K Neuhausen, SL Stoppa-Lyonnet, D Lerman, C Pasini, B de los Rios, P Weber, B Lynch, H
Citation: Sa. Narod et al., Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study, LANCET, 356(9245), 2000, pp. 1876-1881
Dental injuries due to African traditional therapies for diarrhea
Authors: Graham, EA Domoto, PK Lynch, H Egbert, MA
Citation: Ea. Graham et al., Dental injuries due to African traditional therapies for diarrhea, WEST J MED, 173(2), 2000, pp. 135-137
E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer
Authors: Guilford, PJ Hopkins, JBW Grady, WM Markowitz, SD Willis, J Lynch, H Rajput, A Wiesner, GL Lindor, NM Burgart, LJ Toro, TT Lee, D Limacher, JM Shaw, DW Findlay, MPN Reeve, AE
Citation: Pj. Guilford et al., E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer, HUM MUTAT, 14(3), 1999, pp. 249-255
Simulation and measurement of the fringe field of the 1.5 T BABAR solenoid
Authors: Antokhin, E Buzykaev, A Chupyra, A Fedorov, D Ganzhur, S Kolachev, G Litvinov, A Medvedko, A Mikerov, V Mikhailov, S Onuchin, A Singatulin, S Aleksan, R Bourgeois, P Gosset, L Graffin, P London, G Mols, JP Toussaint, JC Berndt, M Coombes, R Ecklund, S Jensen, D Keller, L Krebs, J Lynch, H Wolf, Z
Citation: E. Antokhin et al., Simulation and measurement of the fringe field of the 1.5 T BABAR solenoid, NUCL INST A, 432(1), 1999, pp. 24-47
Linkage analysis of 56 multiplex families excludes the Cowden disease genePTEN as a major contributor to familial breast cancer
Authors: Shugart, YY Cour, C Renard, H Lenoir, G Goldgar, D Teare, D Easton, D Rahman, N Gusterton, R Seal, S Barfoot, R Stratton, M Mangion, J Peelen, T van den Ouweland, A Meijers, H Devilee, P Eccles, D Lynch, H Weber, B Stoppa-Lyonnet, D Bignon, YJ
Citation: Yy. Shugart et al., Linkage analysis of 56 multiplex families excludes the Cowden disease genePTEN as a major contributor to familial breast cancer, J MED GENET, 36(9), 1999, pp. 720-721
Risultati: 1-9 |